NCT04734106View on ClinicalTrials.gov

Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

February 18, 2025

Primary Completion Date

April 30, 2027

Study Completion Date

July 31, 2027

Conditions
Interstitial CystitisChronic Interstitial CystitisBladder Pain Syndrome
Interventions
DRUG

Desert Harvest Aloe Vera Capsules

600 mg pure, freeze-dried aloe vera super-concentrate with a minimum of 200 mg glycosaminoglycan per capsule.

OTHER

Placebo Capsules

550mg of Avicel microcrystalline cellulose per two-piece, hard-shelled gelatin capsule.

Trial Locations (1)

27157

RECRUITING

Wake Forest Baptist Hospital, Winston-Salem

All Listed Sponsors
collaborator

Desert Harvest

UNKNOWN

lead

Wake Forest University Health Sciences

OTHER